- Home
- DARE vs CLEU Comparison
DARE vs CLEU Comparison
Compare DARE & CLEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- CLEU
- Stock Information
- Founded
- DARE N/A
- CLEU 2011
- Country
- DARE United States
- CLEU China
- Employees
- DARE N/A
- CLEU N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- CLEU Other Consumer Services
- Sector
- DARE Health Care
- CLEU Real Estate
- Exchange
- DARE Nasdaq
- CLEU Nasdaq
- Market Cap
- DARE 27.9M
- CLEU 29.3M
- IPO Year
- DARE N/A
- CLEU 2020
- Fundamental
- Price
- DARE $3.17
- CLEU $0.09
- Analyst Decision
- DARE Strong Buy
- CLEU
- Analyst Count
- DARE 4
- CLEU 0
- Target Price
- DARE $20.33
- CLEU N/A
- AVG Volume (30 Days)
- DARE 25.7K
- CLEU 51.5M
- Earning Date
- DARE 03-27-2025
- CLEU 10-11-2024
- Dividend Yield
- DARE N/A
- CLEU N/A
- EPS Growth
- DARE N/A
- CLEU N/A
- EPS
- DARE N/A
- CLEU N/A
- Revenue
- DARE $1,881,316.00
- CLEU $2,413,409.00
- Revenue This Year
- DARE N/A
- CLEU N/A
- Revenue Next Year
- DARE $136.52
- CLEU N/A
- P/E Ratio
- DARE N/A
- CLEU N/A
- Revenue Growth
- DARE 88.13
- CLEU N/A
- 52 Week Low
- DARE $2.67
- CLEU $0.09
- 52 Week High
- DARE $7.56
- CLEU $7.90
- Technical
- Relative Strength Index (RSI)
- DARE 50.64
- CLEU 31.94
- Support Level
- DARE $2.95
- CLEU $0.09
- Resistance Level
- DARE $3.31
- CLEU $0.11
- Average True Range (ATR)
- DARE 0.15
- CLEU 0.02
- MACD
- DARE 0.01
- CLEU -0.10
- Stochastic Oscillator
- DARE 61.11
- CLEU 1.10
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About CLEU China Liberal Education Holdings Limited
China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.